Resultados de procura - Pierfranco Conté

Limitar resultados
  1. 1
    Safety of Intravenous and Oral Bisphosphonates and Compliance With Dosing Regimens

    Safety of Intravenous and Oral Bisphosphonates and Compliance With Dosing Regimens por Pierfranco Conté, Valentina Guarneri

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy

    Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy por Valentina Guarneri, Pierfranco Conté

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations por Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Effects of Sulfonylureas on Tumor Growth: A Review of the Literature

    Effects of Sulfonylureas on Tumor Growth: A Review of the Literature por Giulia Pasello, Loredana Urso, Pierfranco Conté, Adolfo Favaretto

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Heterogeneity of Multipotent Mesenchymal Stromal Cells: From Stromal Cells to Stem Cells and Vice Versa

    Heterogeneity of Multipotent Mesenchymal Stromal Cells: From Stromal Cells to Stem Cells and Vice Versa por Massimo Dominici, Paolo Paolucci, Pierfranco Conté, Edwin M. Horwitz

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities

    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities por Maria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, Pierfranco Conté, Valentina Guarneri

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

    Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges por Alberto Pavan, Ilaria Attili, Giulia Pasello, Valentina Guarneri, Pierfranco Conté, Laura Bonanno

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Cognitive impairment following breast cancer treatments: an umbrella review

    Cognitive impairment following breast cancer treatments: an umbrella review por Giulia Oliva, Andreina Giustiniani, Laura Danesin, Francesca Burgio, Giorgio Arcara, Pierfranco Conté

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

    Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma por Michela Maur, Chiara Tomasello, Antonio Frassoldati, Maria Vittoria Dieci, Elena Barbieri, Pierfranco Conté

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials

    Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials por Valentina Guarneri, Gaia Griguolo, Federica Miglietta, Pierfranco Conté, Maria Vittoria Dieci, Fabio Girardi

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide por Serafino Ricci, Andrea Antonuzzo, Luca Galli, M Ferdeghini, Lisa Bodei, Cinzia Orlandini, Pierfranco Conté

    Publicado 2000
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer por Laura Bonanno, Elisabetta Zulato, Alberto Pavan, Ilaria Attili, Giulia Pasello, Pierfranco Conté, Stefano Indraccolo

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Examining technology-assisted rehabilitation for older adults’ functional mobility: a network meta-analysis on efficacy and acceptability

    Examining technology-assisted rehabilitation for older adults’ functional mobility: a network meta-analysis on efficacy and acceptability por Błażej Cieślik, Justyna Mazurek, Adam Wrzeciono, Lorenza Maistrello, Joanna Szczepańska-Gieracha, Pierfranco Conté, Paweł Kiper

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

    Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials por Maria Vittoria Dieci, M.‐C. Mathieu, Valentina Guarneri, Pierfranco Conté, Suzette Delaloge, Fabrice André, Aïcha Goubar

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer

    Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer por Giulia Pasello, Alberto Pavan, Ilaria Attili, Alberto Bortolami, Laura Bonanno, Jessica Menis, Pierfranco Conté, Valentina Guarneri

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Lack of Benefit of Maintenance Paclitaxel in First-Line Chemotherapy in Metastatic Breast Cancer

    Lack of Benefit of Maintenance Paclitaxel in First-Line Chemotherapy in Metastatic Breast Cancer por Alessandra Gennari, Dino Amadori, Mario De Lena, Oriana Nanni, Paolo Bruzzi, Vito Lorusso, Luigi Manzione, Pierfranco Conté

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

    Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis por Maria Vittoria Dieci, Elena Barbieri, Federico Piacentini, Guido Ficarra, Stefania Bettelli, Massimo Dominici, Pierfranco Conté, Valentina Guarneri

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation

    Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation por Massimo Dominici, Roberta Marino, Valeria Rasini, Carlotta Spano, Paolo Paolucci, Pierfranco Conté, Ted J. Hofmann, Edwin M. Horwitz

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

    Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based c... por Alessandro Buda, Irene Floriani, R Rossi, Nicoletta Colombo, Valter Torri, Pierfranco Conté, R. Fossati, Alessandra Ravaioli, Costantino Mangioni

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?

    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? por Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, Elisabetta Zulato, Lorenzo Calvetti, Giulia Pasello, Valentina Guarneri, Pierfranco Conté, Stefano Indraccolo

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: